Fig. 7.
Analysis of the bronchoalveolar fluid (BALF) cells of the CDIP-2-treated and untreated mice. (a) Analysis of the total BALF cell numbers. Cells were separated from the BALF and counted under microscope as described in Methods. (b) Differential cell counting of the BALF in the CDIP-2-treated mice, compared with those treated with chemokine (C-C motif) ligand 13 (CCL13)-derived (CDP)-1 peptide or saline solution (SS) treatment. Data represent total number of cells ×105 (n = 5) (*P < 0·01). Mac, macrophages; Lym, lymphocytes; Eos, eosinophils; Neu, neutrophils.